361 related articles for article (PubMed ID: 30044345)
21. Elafin as a Predictive Biomarker of Acute Skin Graft-
Solán L; Carbonell D; Muñiz P; Dorado N; Landete E; Chicano-Lavilla M; Anguita J; Gayoso J; Kwon M; Díez-Martín JL; Martínez-Laperche C; Buño I
Front Immunol; 2021; 12():516078. PubMed ID: 33679728
[TBL] [Abstract][Full Text] [Related]
22. Rotavirus infection following post-transplantation cyclophosphamide based haploidentical hematopoietic cell transplantation in children is associated with hemophagocytic syndrome and high mortality.
Jaiswal SR; Bhakuni P; Chakrabarti A; Chakrabarti S
Transpl Infect Dis; 2019 Oct; 21(5):e13136. PubMed ID: 31251433
[TBL] [Abstract][Full Text] [Related]
23. Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide.
Shah NN; Freeman AF; Su H; Cole K; Parta M; Moutsopoulos NM; Baris S; Karakoc-Aydiner E; Hughes TE; Kong HH; Holland SM; Hickstein DD
Biol Blood Marrow Transplant; 2017 Jun; 23(6):980-990. PubMed ID: 28288951
[TBL] [Abstract][Full Text] [Related]
24. Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.
Fernandes JF; Bonfim C; Kerbauy FR; Rodrigues M; Esteves I; Silva NH; Azambuja AP; Mantovani LF; Kutner JM; Loth G; Kuwahara CC; Bueno C; Kondo AT; Ribeiro AAF; Kok F; Hamerschlak N
Bone Marrow Transplant; 2018 Apr; 53(4):392-399. PubMed ID: 29330393
[TBL] [Abstract][Full Text] [Related]
25. Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide in Pediatric Hemophagocytic Lymphohistiocytosis.
Medina-Valencia D; Cleves D; Beltran E; Builes N; Franco AA; Escobar-González AF; Olaya M
J Clin Immunol; 2021 Aug; 41(6):1172-1177. PubMed ID: 33687579
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis.
Fu L; Wang J; Wei N; Wu L; Wang Y; Huang W; Zhang J; Liu J; Wang Z
Int J Hematol; 2016 Nov; 104(5):628-635. PubMed ID: 27431489
[TBL] [Abstract][Full Text] [Related]
27. Haploidentical HSCT in the Treatment of Pediatric Hematological Disorders.
Marszołek A; Leśniak M; Sekunda A; Siwek A; Skiba Z; Lejman M; Zawitkowska J
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928087
[TBL] [Abstract][Full Text] [Related]
28. Upfront Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Children With Severe Aplastic Anemia.
Yadav SP; Thakkar D; Chatterjee G; Kapoor R; Rastogi N
J Pediatr Hematol Oncol; 2020 Nov; 42(8):500. PubMed ID: 33003141
[No Abstract] [Full Text] [Related]
29. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
Gaballa S; Ge I; El Fakih R; Brammer JE; Kongtim P; Tomuleasa C; Wang SA; Lee D; Petropoulos D; Cao K; Rondon G; Chen J; Hammerstrom A; Lombardi L; Alatrash G; Korbling M; Oran B; Kebriaei P; Ahmed S; Shah N; Rezvani K; Marin D; Bashir Q; Alousi A; Nieto Y; Qazilbash M; Hosing C; Popat U; Shpall EJ; Khouri I; Champlin RE; Ciurea SO
Cancer; 2016 Nov; 122(21):3316-3326. PubMed ID: 27404668
[TBL] [Abstract][Full Text] [Related]
30. Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations.
Moiseev IS; Pirogova OV; Alyanski AL; Babenko EV; Gindina TL; Darskaya EI; Slesarchuk OA; Bykova TA; Chukhlovin AB; Pevtcov DE; Bondarenko SN; Afanasyev BV
Eur J Haematol; 2018 May; 100(5):395-402. PubMed ID: 29360184
[TBL] [Abstract][Full Text] [Related]
31. Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation.
Sanchez-Petitto G; Holtzman NG; Bukhari A; Brown M; Morales MK; Koka M; Yared JA; Dahiya S; Rapoport AP; Hardy NM
Transpl Infect Dis; 2020 Apr; 22(2):e13242. PubMed ID: 31895492
[TBL] [Abstract][Full Text] [Related]
32. Recent progress in haploidentical transplantation: is this the optimal choice for alternative donor transplantation?
Watanabe M; Kanda J
Curr Opin Hematol; 2019 Nov; 26(6):406-412. PubMed ID: 31483332
[TBL] [Abstract][Full Text] [Related]
33. [Allogeneic hematopoietic stem cell transplantation using posttransplant cyclophosphamide].
Sugita J
Rinsho Ketsueki; 2020; 61(9):1402-1410. PubMed ID: 33162542
[TBL] [Abstract][Full Text] [Related]
34. Haploidentical Hematopoietic Cell Transplantation Using Post-transplant Cyclophosphamide for Children with Non-malignant Diseases.
Hashem H; Najjar R; Abu-Shanap M; Khattab E; Rihani R; Tbakhi A; Sultan I
J Clin Immunol; 2021 Nov; 41(8):1754-1761. PubMed ID: 34355352
[TBL] [Abstract][Full Text] [Related]
35. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
[TBL] [Abstract][Full Text] [Related]
36. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
Cieri N; Greco R; Crucitti L; Morelli M; Giglio F; Levati G; Assanelli A; Carrabba MG; Bellio L; Milani R; Lorentino F; Stanghellini MT; De Freitas T; Marktel S; Bernardi M; Corti C; Vago L; Bonini C; Ciceri F; Peccatori J
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1506-14. PubMed ID: 26001696
[TBL] [Abstract][Full Text] [Related]
37. High plasma IL-6 levels following haploidentical allogeneic hematopoietic stem cell transplantation post-transplant cyclophosphamide as predictor of early death and worse outcome.
Farias MG; de Mello Vicente B; Habigzang M; Hirakata VN; de Oliveira da Silva P; Paz AA; Daudt LE
Transpl Immunol; 2022 Apr; 71():101543. PubMed ID: 35093504
[TBL] [Abstract][Full Text] [Related]
38. Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experience at a single center.
Dufort G; Castillo L; Pisano S; Castiglioni M; Carolina P; Andrea I; Simon E; Zuccolo S; Schelotto M; Morosini F; Pereira I; Amarillo P; Silveira A; Guerrero L; Ferreira V; Tiscornia A; Mezzano R; Lemos F; Boggia B; Quarnetti A; Decaro J; Dabezies A
Bone Marrow Transplant; 2016 Oct; 51(10):1354-1360. PubMed ID: 27272446
[TBL] [Abstract][Full Text] [Related]
39. Haploidentical Hematopoietic Stem Cell Transplantation for XIAP Deficiency: a Single-Center Report.
Yang J; Zhu GH; Wang B; Zhang R; Jia CG; Yan Y; Ma HH; Qin MQ
J Clin Immunol; 2020 Aug; 40(6):893-900. PubMed ID: 32627096
[TBL] [Abstract][Full Text] [Related]
40. [Clinical study of haploidentical hematopoietic stem cell transplantation on 15 cases of adult-onset primary hemophagocytic lymphohistiocytosis].
Wang YN; Wang JS; Wei N; Wu L; Jin ZL; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):511-516. PubMed ID: 32654467
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
